title: Compartment syndrome caused by computed tomography contrast infiltration seen on a Tc-99m methylene diphosphonate bone scan.
abstract: A 72-year-old man was hospitalized for transurethral resection of bladder cancer. Two days after the procedure, the patient continued to have gross hematuria and a computed tomography (CT) scan of the abdomen and pelvis with intravenous contrast was performed to check the integrity of the resection site. Later that day, the patient underwent technetium-99m methylene diphosphonate (MDP) bone scintigraphy to investigate the possibility of bone metastasis. The bone scan showed no signs of metastasis but did reveal increased uptake of the left hand and forearm on the opposite side of the injection site.
authors: Division of Nuclear Medicine, Maimonides Medical Center, Brooklyn, NY 11219, USA. gperry@optonline.net
authors: Perry S
authors: PS
authors: Gerard
authors: Paul Z
authors: PZ
authors: Gerczuk
authors: Raghu
authors: R
authors: Idupuganti
authors: Madhavi
authors: M
authors: Patnana
authors: Matthew D
authors: MD
authors: Geller
mesh_terms: D000368:Aged; D001132:Arm; D003161:Compartment Syndromes / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D008297:Male; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects*; D013669:Technetium Tc 99m Medronate / Q000008:administration & dosage / Q000009:adverse effects*; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D001749:Urinary Bladder Neoplasms / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate